Growing demand for precision medicine and biomarkers will drive C-reactive protein testing market growth.Wilmington, Delaware, United States, Feb. 15, 2024 (GLOBE NEWSWIRE) Transparency Market Research Inc. - The C-reactive protein testing market was worth US$ 3.1 billion in 2022. A CAGR of 2.9% is projected from 2023 to 2031, and the market will reach more than US$ 4.0 billion in 2031. Integrating data from diverse sources, such as genetic information, electronic health records, and real-tim
Industrial application of icariin and baohuoside I has been hindered by the short supply to a great extent. In this work, a novel GH78 α-l-rhamnosidase AmRha catalyzed the bioconversion of low-value epimedin C in crude Epimedium Folium flavonoids (EFs) to icariin and baohuoside I was developed. Firstly, the high-level expression of AmRha in Komagataella phaffii GS115 attained an enzyme activity of 571.04 U/mL. The purified recombinant AmRha could hydrolyze α-1,2-rhamnoside bond between two rhamnoses (α-Rha(2 → 1)α-Rha) in epimedin C to produce icariin with a molar conversion rate of 92.3%, in vitro. Furtherly, the biotransformation of epimedin C to icariin by the recombinant Komagataella phaffii GS115 cells was also investigated, which elevated the EFs concentration by fivefold. In addition, biotransformation of epimedins A-C and icariin in the raw EFs to baohuoside I was fulfilled by a collaboration of AmRha and β-glucosidase/β-xylosidas
/PRNewswire/ The global magnetic beads market size is estimated to increase by USD 1,672.62 million from 2022 to 2027. The market s growth momentum will.
According to the deep-dive market assessment study by Growth Plus Reports, the global nucleic acid decontamination reagents market was valued at US$ 1.75 billion in 2022 and is expected to register a revenue CAGR of 8.4% to reach US$ 3.61 billion by 2031.